THE RATIO OF THROMBOXANE TO PROSTACYCLIN IS INCREASED BY PEROXIDE IN A DOSE-DEPENDENT MANNER, ALONG WITH INCREASED VASOCONSTRICTION IN THE HUMAN PLACENTA
Yp. Wang et Sw. Walsh, THE RATIO OF THROMBOXANE TO PROSTACYCLIN IS INCREASED BY PEROXIDE IN A DOSE-DEPENDENT MANNER, ALONG WITH INCREASED VASOCONSTRICTION IN THE HUMAN PLACENTA, Hypertension in pregnancy, 17(1), 1998, pp. 1-11
Objective: To determine if perfusion of the human placenta with increa
sing doses of exogenous peroxide will result in a dose-dependent incre
ase in the ratio of thromboxane to prostacyclin, and a progressive inc
rease in placental vasoconstriction. Methods: Isolated human placental
cotyledons (n = 7) were perfused serially for 20-min intervals with c
ontrol Krebs-Ringer-bicarbonate (KRB) buffer gassed with 95% O-2 and 5
% CO2,, and then KRB buffer containing progressively increasing concen
trations of t-butyl hydroperoxide (10, 25, 50, and 100 mu mol/L). Cont
rol KRB buffer was perfused between each dose of t-butyl hydroperoxide
. Perfusion pressure was continually monitored and maternal and fetal
effluent samples were collected and analyzed for thromboxane and prost
acyclin by their stable metabolites, TXB2, and 6-keto PGF(1 alpha). Re
sults: Compared to control KRB buffer, perfusion with t-butyl hydroper
oxide at concentrations of 25, 50, and 100 mu mol/L resulted in a prog
ressive and significant increase in the fetal secretion rate ratio of
thromboxane to prostacyclin (22.9 +/- 7.9 vs. 29.1 +/- 7.3, 38.8 +/- 2
.3, and 52.4 +/- 8.9, respectively). Peroxide significantly increased
the thromboxane secretion rate on the fetal side (0.52 +/- 0.2 ng/min
vs. 1.3 +/- 0.38 ng/min, 1.4 +/- 0.31 ng/min, and 1.9 +/- 0.24 ng/min)
, as well as on the maternal side (3.3 +/- 0.75 ng/min vs. 5.4 +/- 0.8
2 ng/min, 6.1 +/- 0.96 ng/min, and 7.5 +/- 1.2 ng/min) for the 25, 50,
and 100 mu mol/L concentrations, respectively. Peroxide perfusion did
not have a significant effect on the fetal secretion rate of prostacy
clin, and maternal secretion of prostacyclin was nondetectable. Coinci
dent with the increase in the thromboxane to prostacyclin ratio, perox
ide also increased the perfusion pressure (PP) and vascular resistance
(VR) in a dose-dependent manner for the 25, 50, and 100 mu mol/L conc
entrations (PP: 32.9 +/- 2.5 mm Hg for control vs. 39.0 +/- 5.6 mm Hg,
39.7 +/- 2.5 mm Hg, and 50.4 +/- 2.9 mm Hg; VR: 13.8 +/- 1.9 mm Hg.mi
n/mL vs. 16.2 +/- 2 mm Hg.min/mL, 16.6 +/- 1.8 mm Hg.min/mL, and 21.7
+/- 2.2 mm Hg.min/mL, respectively), The increases in perfusion pressu
re and vascular resistance were highly correlated with the increase in
the thromboxane to prostacyclin ratio (r = 0.826 and r = 0.848, respe
ctively). Conclusions: Perfusion of the isolated human placental cotyl
edon with progressively increasing concentrations of peroxide-resulted
in a progressive increase in the ratio of thromboxane to prostacyclin
. The increase in the ratio was due to the stimulation of thromboxane.
There were also progressive increases in perfusion pressure and vascu
lar resistance that were highly correlated with the increase in the th
romboxane to prostacyclin ratio.